The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $629,162 in first-year total cost, median $170,260.
Most frequent study sections
- Special Emphasis Panel[ZDK1 GRB-7 (O4)]3
Most frequent institutions
- GEORGIA INSTITUTE OF TECHNOLOGY1
- MASSACHUSETTS GENERAL HOSPITAL1
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Understanding the role of Epigenetic Reader SP140 in IBD1R01DK119996-01 | JEFFREY, KATE LOUISA | MASSACHUSETTS GENERAL HOSPITAL, MA | $298,818 | ZDK1 |
| 2018 | New computational, transcriptional, and genome editing approaches to the biology of inflammatory bowel disease1R01DK119991-01 | GIBSON, GREGORY C | GEORGIA INSTITUTE OF TECHNOLOGY, GA | $170,260 | ZDK1 |
| 2018 | Functional Molecular Investigation of Inflammatory Bowel Disease (IBD) Risk Variants1R01DK119979-01 | MARSON, ALEXANDER | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA | $160,084 | ZDK1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-11-0.1.2. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.